John Chalmers AC's Publications
About John Chalmers AC's Publications
Senior Director, Professorial Unit, The George Institute (Australia)- Professor of Medicine, UNSW Sydney
- Emeritus Professor of Medicine at Flinders University and at the University of Sydney
- FAA,
- FAHMS,
- FRACP
-
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
The Lancet Oncology Date published: -
STRATIFIED EFFECTS OF BLOOD PRESSURE-LOWERING TREATMENT ON LONG-TERM BLOOD PRESSURE: A META-ANALYSIS OF INDIVIDUAL-LEVEL DATA OF 334,219 PARTICIPANTS FROM 50 RANDOMIZED TRIALS
Journal of Hypertension Date published: -
IMPACT OF MODEL CHOICE WHEN STUDYING THE RELATIONSHIP BETWEEN BLOOD PRESSURE VARIABILITY AND RISK OF STROKE
Journal of Hypertension Date published: -
EFFECTS OF BLOOD PRESSURE-LOWERING ON CANCER RISK: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 300,000 PARTICIPANTS
Journal of Hypertension Date published: -
PLASMA FATTY ACIDS AND THE RISK OF VASCULAR AND MORTALITY OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE STUDY
Journal of Hypertension Date published: -
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398
Diabetes Care Date published: -
Author response for "Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial"
Unknown Date published: -
Excise taxes on sugar-sweetened beverages in Latin America and the Caribbean
Revista Panamericana de Salud Pública Date published: -
Excise taxes on sugar-sweetened beverages in Latin America and the Caribbean
Revista Panamericana de Salud Pública Date published: -
The impact of baseline potassium intake on the dose-response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials
Journal of Human Hypertension Date published: -
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial
Diabetes, Obesity and Metabolism Date published: -
Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes
Canadian Journal of Diabetes Date published: -
Abstract MP3: Low Dose versus Standard Dose Alteplase in Acute Lacunar Ischemic Stroke
Stroke Date published: -
The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial
Diabetes, Obesity and Metabolism Date published: -
Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage
Stroke Date published: -
Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke
Neurology Date published: